BHS 323 Writing Assignment #4

Prompt: Choose one of the primary research or clinical trial articles that was in your reference list for your midterm audience essay, and write a rhetorical precis on the article.

(1) David L. Suskind, MD, Mitchell J. Brittnacher, PhD, Ghassan Wahbeh, MD, Michele L. Shaffer, PhD,Hillary S. Hayden, PhD,Xuan Qin, PhD, Namita Singh, MD, Christopher J. Damman, MD, Kyle R. Hager, Heather Nielson, and Samuel I. Miller, MD, from the Department of Pediatrics, Division of Gastroenterology with Seattle Children’s Hospital with the University of Washington in an original, clinical trial entitled “Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn’s Disease” (2015) demonstrates that changing the fecal dysbiosis of patients with CD can promote a decrease in intestinal inflammation. (2) Suskind et al. provides evidence that FMT is a potentially therapeutic option for patients with CD by looking at 9 patients with mild-to-moderate symptoms and measuring decreases in symptoms as defined by the Pediatric Crohn’s Disease Activity Index. (3) The purpose of this study is to describe the ability of patients with CD to show improvement and regression of disease with fecal microbial transplant in order to assess the safety and efficacy of FMT in patients with CD. (4) Suskind et al. establishes a scholarly relationship in medical academia within the University of Washington and Seattle Children’s Hospital as well as other gastrointestinal specialty centers throughout the country. 


Suskind DL, Brittnacher MJ, Wahbeh G, Shaffer ML, Hayden HS, Qin X, Singh N, Damman CJ, Hager KR, Nielson H, Miller SI. 2015. Fecal Microbial Transplant Effect on Clinical Outcomes and Fecal Microbiome in Active Crohn’s Disease. Inflammatory bowel disease 21: 556-563.

Print Friendly, PDF & Email

Leave a Reply

Your email address will not be published. Required fields are marked *